HALO EPS Estimates
Halozyme Therapeutics, Inc.
$116.82
+$7.20(+6.57%)
62
Overall
60
Value
63
Tech
65
Quality
Market Cap
$13.26B
Volume
3.75M
52W Range
$61.23 - $116.85
Target Price
$101.30
HALO EPS estimates: the consensus estimate for Halozyme Therapeutics, Inc.'s current fiscal year is $8.25 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
HALO EPS Estimates
- EPS estimate, current quarter
- $2.13
- EPS estimate, next quarter
- $2.47
- EPS estimate, current year
- $8.25
- EPS estimate, next year
- $9.33
- EPS growth, 3-year
- +21.28%
| Fiscal year | EPS |
|---|---|
| 2025 | $2.64 |
| 2024 | $3.50 |
| 2023 | $2.13 |
| 2022 | $1.48 |
| 2021 | $2.86 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | HALO | $116.82 | +6.6% | 3.75M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Halozyme Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW